FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/04/2023
Back to search
Official data from USPTO
EXPLORASPHERE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EXPLORASPHERE
ST13
US500000079350385Class
5, 9, 10, 35, 38, 42
Filing
79350385
Registration
7070826
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
10/04/2023
Trademark type
Word
Nice classes
5, 9, 10, 35, 38, 42
Filing date
02/23/2022
Registration date
06/06/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/06/2023
Last transaction
06/06/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
25
Owner location
CH
Examiner
HSU, FONG
Law office
O20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
NOVARTIS AG
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 5Class 9Class 10Class 35Class 38Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Class 9
downloadable software for management of patient medical information
Class 10
Medical and surgical apparatus and instruments for diagnosing and treating cardiovascular diseases; Medical and surgical apparatus and instruments for diagnosing and treating dermatological diseases; medical and surgical apparatus and instruments for diagnosing and treating respiratory diseases and disorders; medical and surgical apparatus and instruments for diagnosing and treating central nervous system diseases; medical and surgical apparatus and instruments for diagnosing and treating gastro-intestinal diseases; medical and surgical apparatus and instruments for the diagnosisprevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; medical and surgical apparatus and instruments for use in hematology and in tissue and organ transplantation; medical and surgical apparatus and instruments for the diagnosisprevention and treatment of eye diseases and conditions; medical and surgical apparatus and instruments for the diagnosisprevention and treatment of heart rhythm disorders; medical and surgical apparatus and instruments for the diagnosisprevention and treatment of immune system related diseases and disorders; medical and surgical apparatus and instruments for the diagnosisprevention and treatment of kidney diseases; medical and surgical apparatus and instruments for the diagnosisprevention and treatment of diabetes; medical and surgical apparatus and instruments for the diagnosisprevention and treatment of hypertension; medical and surgical apparatus and instruments for the diagnosisprevention and treatment of skin disorders; medical and surgical apparatus and instruments for use in urology; medical and surgical apparatus and instruments for ophthalmological use; medical and surgical apparatus and instruments for the diagnosisprevention and treatment of cancer and tumors; medical and surgical apparatus and instruments for the diagnosisprevention and treatment of allergies; medical and surgical apparatus and instruments for the diagnosisprevention and treatment of bone diseases; medical and surgical apparatus and instruments for the diagnosisprevention and treatment of respiratory diseases and asthma; radiological apparatus and instruments for medical and surgical use; genetic testing apparatus and instruments for medical use; electromagnetic drug delivery apparatus and instruments for medical use; medical and surgical apparatus and instruments for diagnostic radiopharmaceutical use; medical and surgical apparatus and instruments for facilitating the inhalation of pharmaceutical preparations; apparatus and instruments for DNA and RNA testing for medical and surgical use; medical apparatusinfusion and injection devices for administering drugs; medical and surgical apparatus and instruments for introducing pharmaceutical preparations into the human body
Class 35
Advertisingmarketing and promotional services relating to pharmaceuticals
Class 38
Providing online chat rooms and electronic bulletin boards for the transmission of messages among users in the fields of healthcarepharmaceuticalsdevelopments therein; Transmission of information in the field of pharmaceutical preparations; broadcasting servicestransmission of advertising programs and media advertising communications via digital communication networks
Class 42
Scientific research services; Hosting websites featuring educational content in the field of health
Publications
History of USPTO decisions and trademark events.
29 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/12/2023
FIMP
FINAL DISPOSITION PROCESSED
09/12/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/06/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/06/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
06/06/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/21/2023
PUBO
PUBLISHED FOR OPPOSITION
03/21/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/01/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/13/2023
RFNP
REFUSAL PROCESSED BY IB
02/07/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/21/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/20/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/20/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/13/2023
RFRR
REFUSAL PROCESSED BY MPU
01/13/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/13/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/13/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/13/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/13/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/13/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/13/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/02/2022
CNRT
NON-FINAL ACTION WRITTEN
11/01/2022
DOCK
ASSIGNED TO EXAMINER
10/31/2022
MAFR
APPLICATION FILING RECEIPT MAILED
10/04/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/30/2022
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
09/29/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/22/2022
Continuous trademark protection
Get notified about every new filing that threatens EXPLORASPHERE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.